Cargando…
Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy?
Temozolomide is an oral alkylating agent that is used as the first line treatment for glioblastoma multiform, and in recurrent anaplastic astrocytoma, as well as having demonstrable activity in patients with metastatic melanoma. However, as the case with other chemotherapeutic agents, the developmen...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954434/ https://www.ncbi.nlm.nih.gov/pubmed/36831202 http://dx.doi.org/10.3390/cells12040535 |